Register
Login:
Share:
Email Facebook Twitter

Ariana forecast 47% rise in Kiziltepe gold production Watch here

Ariana forecast 47% rise in Kiziltepe gold production


Reuters Finance & Stock Market News






UPDATE 7-Oil climbs on Saudi price ambitions and U.S. stocks draw

* Saudi Arabia seen seeking oil price of $80-$100 a barrel* Market expects renewed U.S. sanctions against Iran* U.S. commercial crude stocks decline towards five-year
[19 Apr '18 04:32]

Amazon.com secures U.S. Open tennis rights in UK and Ireland

LONDON, April 19 (Reuters) - Amazon.com confirmed on Thursday it has secured UK and Ireland rights to broadcast the US Open Tennis Championship, addin
[19 Apr '18 14:00]

UPDATE 1-Takeda in talks with Shire after $61 bln bid rejected

(Recasts with details of Takeda confirming bid)By Ben Martin, Greg Roumeliotis and Ben HirschlerLONDON/NEW YORK, April 19 (Reuters) - Japan's Takeda
[19 Apr '18 13:58]

UPDATE 2-Currency trading volumes hit record highs in first quarter

* CLS sees record Q1 for FX volumes* Thomson Reuters has back-to-back record months* April quieter, raising worries volume spike short-lived
[19 Apr '18 11:27]

RPT-UPDATE 2-Takeda makes $61 bln bid for drugmaker Shire -sources

(Repeats to fix transmission problem. Adds detail)By Greg Roumeliotis and Ben MartinLONDON, April 19 (Reuters) - Takeda Pharmaceutical
[19 Apr '18 13:07]

WRAPUP-Nestle, Unilever forego price increases to move product

* Nestle beats, Unilever meets analysts' forecasts* Volume picks up but pricing slows* Nestle shares up, Unilever down* P&G also sees volume growth offset weak pricing
[19 Apr '18 13:36]

UPDATE 1-Strike halts gold output at two Randgold mines in Mali -union

(Adds details, background)BAMAKO, April 19 (Reuters) - A strike has halted gold
[19 Apr '18 13:34]

LIVE MARKETS-Midsession snapshot: small moves but Shire spikes

* European stocks edge up
[19 Apr '18 13:30]

Takeda in talks with Shire after 46.50 stg/shr bid rejected

LONDON, April 19 (Reuters) - Japan's Takeda Pharmaceutical
[19 Apr '18 13:23]

UPDATE 4-Novartis CEO feels heat on U.S. generics, Cosentyx drop

* Novartis confirms 2018 targets* Alcon recovery continues, 2019 spin-off possible* Cosentyx sales drop since Q4 worries analysts
[19 Apr '18 07:15]





Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.